English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background : The bioavailability of a generic preparation of aceclofenac (Omenol from Korea United Pharmaceutical Company) was evaluated in comparison with a proprietary product (Losec from Astra Pharmaceutical Company). Methods : Sixteen healthy male volunteers participated in the study conducted according to a two-way crossover, open-labeled Latin square design. The bioavailability was compared using the parameters total area under the plasma concentration-time curve (AUC0-∞ ), peak plasma concentration (Cmax) and time to reach peak plasma concentration (Tmax) Results : No statiscally significant difference was observed between the values of the two products in all three parameters. The difference of mean of AUC0-∞ and Cmax values of Omenol over those of Losec was found to lie between 8.05% and 2.49%, respectively, being within the acceptable bioequivalence limit of 20%. Conclusion : These findings indicate that the two preparations are comparable in the extent and rate of absorption.

Bioequivalence Study of a Generic Omeprazole Capsule Preparation